We are live on ! Find out more
S

Sanofi Portfolio holdings

AUM $534M
1-Year Est. Return 205.96%
This Fund
S&P 500
This Quarter Est. Return
+37.72%
1 Year Est. Return
+205.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$534M
AUM Growth
+$198M
Cap. Flow
+$47.8M
Cap. Flow %
8.95%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ODTX
Odyssey Therapeutics
ODTX
+$34.9M
2
TRAX
First Tracks Biotherapeutics
TRAX
+$15.4M

Top Sells

Rank Stock Value
1
ELDN icon
Eledon Pharmaceuticals
ELDN
+$2.51M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGTX icon
1
MeiraGTx Holdings
MGTX
$1.24B
$165M 30.86%
12,197,737
– –
INBX icon
2
Inhibrx
INBX
$1.63B
$110M 20.54%
1,157,926
– –
NVAX icon
3
Novavax
NVAX
$1.58B
$64.8M 12.14%
6,880,481
– –
ANAB icon
4
AnaptysBio
ANAB
$1.6B
$55.5M 10.39%
821,917
– –
ODTX
5
Odyssey Therapeutics
ODTX
$1.17B
$37.3M 6.98%
+1,991,918
New +$34.9M
AGMB
6
AgomAb Therapeutics NV
AGMB
$605M
$36.1M 6.76%
2,783,096
– –
MPLT
7
MapLight Therapeutics
MPLT
$610M
$32.7M 6.12%
912,041
– –
TRAX
8
First Tracks Biotherapeutics
TRAX
$1.34B
$16.5M 3.1%
+821,917
New +$15.4M
IMRX icon
9
Immuneering
IMRX
$280M
$13.5M 2.53%
2,708,559
– –
QTTB icon
10
Q32 Bio
QTTB
$325M
$3.11M 0.58%
244,083
– –
ELDN icon
11
Eledon Pharmaceuticals
ELDN
$225M
– –
-814,980
Closed -$2.51M

Similar funds

BCM
Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $534M AUM 51.9% 1-Year Est. Return
CWM
Cranbrook Wealth Management Bloomfield Hills, Michigan $534M AUM 18.5% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $533M AUM 20.75% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
SDAM
Shulman DeMeo Asset Management Lake Success, New York $535M AUM 24.42% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $535M AUM 19.4% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Sanofi's Q2 2026 Portfolio in Review

As of Q2 2026, Sanofi held 11 positions worth $534M, up 59% from $336M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sanofi deployed $47.8M of net new capital in Q2 2026, opening 2 new positions. Its largest new stake was Odyssey Therapeutics: 1,991,918 shares worth $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Eledon Pharmaceuticals, an estimated $2.51M sold.

  • Sanofi's largest Q2 2026 buy was Odyssey Therapeutics: 1,991,918 shares worth $37.3M.
  • Sanofi fully exited Eledon Pharmaceuticals in Q2 2026, selling an estimated $2.51M.
  • Sanofi's ten largest holdings make up 100% of its $534M portfolio in Q2 2026.
  • Sanofi opened 2 new positions and closed 1 in Q2 2026.
  • Sanofi's portfolio value rose 59% quarter-over-quarter to $534M.

Based on Sanofi's 13F filing for Q2 2026, filed 28 Jul 2026.